Forward-Looking Statements and Article Accuracy : This article reflects information available as of June 2026 and was prepared using reasonable care to be accurate and useful at the time of publication
Further clarification of the correlation between DHRS7 and immune-infiltrating cells revealed positive correlation with macrophages, particularly M2-type macrophage infiltration
Consultation with a healthcare professional is recommended prior to its long-term use in PCOS management
on the other hand, its chemical structure has a completely different nature and lacks the genuine peptide character, so different interactions with micelles can be expected
Key Points Activation of the androgen receptor (AR) is crucial for tumor cell progression and survival of prostate cancer, and androgen deprivation therapy remains the main clinical approach in men with locally advanced tumors Current therapies incompletely suppress the androgenAR axis, but a multiple therapeutic approach, targeting androgens and their receptor, has potential to improve clinical outcomes Treatment of prostate cancer cells with 5-reductase inhibitors (5ARIs) inhibits cellular pathways regulating metabolism, cell growth and proliferation, triggering apoptosis and decreasing prostate size Although 5ARI treatment reduces the risk of developing prostate cancer, patients treated with these drugs have tumors with higher Gleason scores than those who receive placebo Use of 5ARIs to prevent and treat prostate cancer remains controversial, and further investigation is necessary to understand the presence of more-aggressive tumors in patients receiving these drugs This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
